Federation of Clinical Immunology Societies Inc

Nonprofit profile at a glance

EIN
760715404
IRS 990 coverage
2011–2024
Forms available
Form 990 2024, Form 990-T 2024
Location
Menomonee Falls, WI, USA
Phone
4143591670
Rating
80
Verdict
STRONG
Rating confidence
Moderate
Sector
Medical Disciplines

Reported finances

Revenue
$1,302,486
Expenses
$1,694,426
Assets
$1,753,506
Liabilities
$50,468

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

20 people listed

Executive titles in this filing

  • IGNACIO ANEGON (PRESIDENT)
  • MEGAN LEVINGS (PRESIDENT-ELECT (FROM JUNE 2024))
  • MEGAN SYKES (PAST PRESIDENT)
  • MARK ANDERSON (PAST PRESIDENT (THRU JUNE 2024))
  • CALEY MUTRIE (EXECUTIVE DIRECTOR)

People named in this filing

  • IGNACIO ANEGON (PRESIDENT)
  • MEGAN LEVINGS (PRESIDENT-ELECT (FROM JUNE 2024))
  • WILLIAM ROBINSON (SECRETARY/TREASURER)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The mission of the federation of clinical immunology societies (focis) is to apply the science of immunology to improve human health through interdisciplinary research, education, communication, and collaboration.

What it reported doing in 2024

Focis has the following educational courses: advanced course, basic immunology in medicine course, systems immunology course, cancer immunity & immunotherapy course, and basic immunology in medicine to go. Advanced course invited speakers lecture on the major topics in cellular and molecular immunology, including innate immunity, b cells, t cells, and cytokines. Special sessions cover new advances in interventional clinical immunology and the molecular and genetic basis of immune-mediated diseases. There will be ample opportunity for students to interact with the faculty outside the lecture room. Basic immunology in medicine course review selected topics in basic immunology, with emphasis on recent advances and issues that are relevant to the pathogenesis and treatment of immune-mediated inflammatory diseases. Systems immunology course is aimed at scientists involved or interested in the use of multi-dimensional data generated by modern genomics and proteomics technologies such as mass/flow cytometry, next-generation sequencing and microarrays. The course will also provide a better basic understanding of modern statistical and mathematical concepts necessary for their analysis and interpretation. Cancer immunity & immunotherapy course reviews tumor immunology as the scientific foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations, and near-term opportunities for further accelerating clinical progress. Basic immunology in medicine to go is an up-to-date, clinically relevant overview of how the immune system functions and malfunctions, presented in a manner that is accessible and of interest to individuals with various levels of scientific knowledge. The course helps industry employees understand the clinical relevance, mechanisms of actions and potential complications of drugs their companies are developing or marketing in the area of immune/inflammatory diseases.

Operating model

Revenue model
Earned-program. 94% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Fundraising costs are high for each dollar raised and expenses are high relative to revenue.

Rating breakdown

  • Financial Efficiency: 83
  • Transparency & Controls: 90
  • Accountability: 88
  • Sustainability: 32
  • Growth: 20

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 81.4%; rating input score 81
  • Fundraising efficiency: $0.01 raised per $1 spent on fundraising; rating input score 1; 1st percentile among comparable filings

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 5 of 7 controls in place; rating input score 71
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -30.1%; rating input score 6; 6th percentile among comparable filings
  • Total-asset coverage ratio: 1.03; rating input score 44; 44th percentile among comparable filings
  • Liabilities to assets ratio: 0.03; rating input score 59; 59th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 81; 81st percentile among comparable filings

Growth

  • Program expense growth: -1.9% per year; rating input score 0; 12th percentile among comparable filings
  • Revenue growth: -0.7% per year; rating input score 0; 12th percentile among comparable filings
  • Asset growth: 4% per year; rating input score 100; 34th percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 81.4% of spending went to programs
  • Governance: 16 of 16 board members independent · 5 of 7 filing controls reported
  • Programs: 2 filed program accomplishments · $1.4M in reported program spending
  • Leadership: top reported pay $0 · 20 people listed
  • Highest-paid contractors: 2 contractors listed · $782K reported
  • Consistency: 23 of 23 current checks pass
  • Schedules: 2 filed schedules
  • Filing history: 13 filing years from 2011 to 2024
  • Contacts: How to reach this organization
  • Money network: Resolved incoming and outgoing counterparties from filed money flows.
  • Related organizations: Filed and resolved organization relationships.
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Fundraising efficiency scored 1/100.
  • High — Sustainability: Operating margin scored 6/100.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Review — Accountability: Governance controls: Independent financial-statement audit not reported.
  • Moderate — Sustainability: Total-asset coverage ratio scored 44/100.
  • Review — Sustainability: Liabilities to assets ratio scored 59/100.